May 5, 2017
Consultation Document, Protecting Canadians from Excessive Drug Prices Patented Medicine Prices Review Board (PMPRB) and the Patented Medicines Regulations Innovative Medicines Canada is the national voice of Canada’s innovative pharmaceutical […]
For more than a century, Canada has been at the forefront of medical innovation. From the discovery of insulin to advances in stem cell research, Canadians have made significant scientific […]
This strategic partnership will identify ways to attract investment, expand research, improve patient access to medicines and, ultimately…
Toronto, April 27, 2017 – In response to the budget tabled by Ontario Finance Minister Charles Sousa, Innovative Medicines Canada welcomes the Government of Ontario’s initiative to launch OHIP+, a […]
Innovative Medicines Canada is pleased to announce the appointment of Pamela Fralick as President. Ms. Fralick is an experienced leader who has been fostering positive change in Canada’s health sector […]
